Suchergebnisse - "Piccirillo, Maria Carmela"

PubPharm (140)

1

THE TIME COURSE OF THERAPEUTIC INTERVENTIONS FOR COVID-19

enthalten in: bioRxiv.org | 2024

von Ngo, B. | Marik, P. | Kory, P. | +33

2

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France : a phase 3, open-label, randomised controlled trial

enthalten in: Lancet (London, England) | 2023

von Chu, Q. | Perrone, F. | Greillier, L. | +32

CommentIn: Lancet. 2023 Dec 16;402(10419):2266-2267. - PMID 37931626

3

Brief Report : Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Piccirillo, M. | Chu, Q. | Bradbury, P. | +32

CommentIn: J Thorac Oncol. 2023 Jun;18(6):e67-e68. - PMID 37210188

4

Response to a Letter Received Entitled : "'Brief Report: Canadian Cancer Trials Group IND.227': Unpacking the Clinical Potential of Single-Agent Pembrolizumab in Advanced Malignant Pleural Mesothelioma"

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Piccirillo, M. | Chu, Q. | Bradbury, P. | +1

CommentOn: J Thorac Oncol. 2023 Jun;18(6):813-819. - PMID 36841541

5

Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center : Results of a Prospective Analysis

enthalten in: JCO oncology practice | 2023

von Morabito, A. | Mercadante, E. | Muto, P. | +21

6

Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 prospective phase 2 trial

enthalten in: bioRxiv.org | 2022

von Perrone, F. | Piccirillo, M. | Ascierto, P. | +33

7

BRAF Inhibitors in Non-Small Cell Lung Cancer

enthalten in: Cancers | 2022

von Sforza, V. | Palumbo, G. | Cascetta, P. | +15

8

Breast Cancer Survivorship : the Role of Rehabilitation According to the International Classification of Functioning Disability and Health-a Scoping Review

enthalten in: Current oncology reports | 2022

von Pinto, M. | Calafiore, D. | Piccirillo, M. | +3

9

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC : The BEVERLY Multicenter Randomized Phase 3 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Piccirillo, M. | Bonanno, L. | Garassino, M. | +30

10

Breast Cancer Survivorship: the Role of Rehabilitation According to the International Classification of Functioning Disability and Health—a Scoping Review

enthalten in: Current oncology reports | 2022

von Pinto, M. | Calafiore, D. | Piccirillo, M. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]